title: Prognosis value of residual disease monitoring by polymerase chain reaction in patients with CBF beta/MYH11-positive acute myeloblastic leukemia.
authors.forename: R
authors.initials: R
authors.lastname: Costello
authors.forename: D
authors.initials: D
authors.lastname: Sainty
authors.forename: D
authors.initials: D
authors.lastname: Blaise
authors.forename: J A
authors.initials: JA
authors.lastname: Gastaut
authors.forename: J
authors.initials: J
authors.lastname: Gabert
authors.forename: H
authors.initials: H
authors.lastname: Poirel
authors.forename: A
authors.initials: A
authors.lastname: Buzyn-Veil
authors.forename: E
authors.initials: E
authors.lastname: Macintyre
mesh_terms: D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics*; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011237:Predictive Value of Tests; D011379:Prognosis
chemical_list: C095514:CBFbeta-MYH11 fusion protein; D015514:Oncogene Proteins, Fusion